Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Vonoprazan Compared to Placebo in Participants With Symptomatic Non-Erosive Gastroesophageal Reflux Disease [Phase 2]

View source ↗

Summary

Phase 2 trial comparing vonoprazan to placebo in symptomatic non-erosive gastroesophageal reflux disease has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heartburn
• Non-erosive Gastroesophageal Reflux Disease

Drugs mentioned

• Vonoprazan (vonoprazan)

Snippet

Sponsor: Phathom Pharmaceuticals, Inc. | Conditions: Non-Erosive Gastro-Esophageal Reflux Disease, Heartburn | Phase 2 | Status: COMPLETED | Results posted: 2023-01-04